Translation is a basic cellular process and its capacity is adapted to cell function. In particular, secretory cells achieve high protein synthesis levels without triggering the protein stress response. It is unknown how and when translation capacity is increased during differentiation. Here, we show that the transcription factor Creb3l2 is a scaling factor for translation capacity in secretory cells and that it directly binds ~75% of regulatory and effector genes for translation. In parallel with this cell-autonomous mechanism, implementation of the physiological UPR pathway prevents triggering the protein stress response. The pituitary differentiation factor Tpit activates Creb3l2 expression, the Creb3l2dependent regulatory network as well as the physiological UPR pathway. Thus, Creb3l2 implements high basal translation levels through direct targeting of translation effector genes acting downstream of signaling pathways that otherwise regulate protein synthesis.
Abstract
Translation is a basic cellular process and its capacity is adapted to cell function. In particular, secretory cells achieve high protein synthesis levels without triggering the protein stress response. It is unknown how and when translation capacity is increased during differentiation. Here, we show that the transcription factor Creb3l2 is a scaling factor for translation capacity in secretory cells and that it directly binds ~75% of regulatory and effector genes for translation. In parallel with this cell-autonomous mechanism, implementation of the physiological UPR pathway prevents triggering the protein stress response. The pituitary differentiation factor Tpit activates Creb3l2 expression, the Creb3l2dependent regulatory network as well as the physiological UPR pathway. Thus, Creb3l2 implements high basal translation levels through direct targeting of translation effector genes acting downstream of signaling pathways that otherwise regulate protein synthesis.
Expression of Creb3l2 may be a useful means to enhance production of therapeutic proteins. In addition to the 100-fold increase of POMC mRNA levels in adults 15 , examination of POMC cells suggested that they increase in volume during postnatal development. We took advantage of POMC-EGFP reporter mice 15 to analyze by FACS the time course of this increase. Both melanotropes and corticotropes increase in size between postnatal days P1 and P40, with greater amplitude in melanotropes ( Fig. 1p, q ). In addition, an increase of cell granularity was observed ( Fig. 1r ), suggesting an expansion of organelle content. In summary, maturation of POMC cell secretory capacity is implemented during the postnatal period and it is triggered by Tpit.
Creb3l2, a Tpit-dependent regulator
To gain insights into the molecular mechanisms of Tpit-dependent POMC cell maturation, we compared gene expression profiles of WT and Tpit KO IL that contain mostly melanotropes 21 . Fig. S1a -c) revealed 2697 differentially-expressed transcripts using a P-value cut-off P<0.001 ( Fig. 2a and Supplementary Table S1 ). Gene Ontology (GO) analysis revealed that the most significantly enriched biological processes (BP) associated with 1578 transcripts downregulated in Tpitdeficient IL are intracellular protein transport, secretory pathway and translation (Fig. 2b) . In particular and as validated by RT-qPCR, major regulators of the UPR pathway -XBP1, ATF4 and ATF6, as well as numerous downstream UPR pathway, vesicle-mediated transport and translation control genes are Tpit-dependent ( Fig. 2c,d) . These genes were not downregulated in Pomc-KO ILs (Fig. 2d ). Hence, expression of Tpit, but not POMC, correlates positively with that of secretory pathway genes. Interestingly, UPR genes associated with translational Supplementary Fig. S1d ). In addition, expression of Ppp1r15a/Gadd34/Myd116 (phosphatase that reverses inhibitory eIF2 phosphorylation) and Naip5-Naip6 (anti-apoptotic genes) is decreased in Tpit KO IL.
Comparison of WT versus KO gene expression profiles (Supplementary
Therefore, Tpit action correlates with activation of some branches of the UPR pathways but not with those involved in translational attenuation, disposal of misfolded proteins and programmed cell death that are part of the classical XBP1-dependent UPR stress response.
These differences distinguish the physiological UPR from the ER stress-related UPR response.
The non-canonical bZIP TF Creb3l2 is the most downregulated gene of this subfamily in Tpit KO ( Fig. 2c,d and Supplementary Fig. S1e ) and it is noteworthy that the pituitary is a major tissue of Creb3l2 expression ( Supplementary Fig. S1f ). Expression of both Creb3l2 and XBP1, the classical UPR responsive TF, follow the Tpit/POMC postnatal expression profile ( Fig. 2e ), in agreement with the hypothesis that they mediate Tpit actions on postnatal maturation of POMC cells. In order to correlate Tpit-dependence with Tpit action, we queried the Tpit ChIPseq data 22 for direct binding to putative Creb3l2 regulatory sequences. Strong Tpit binding (8 th highest peak out of 17190) is present in the first intron of the Creb3l2 gene ( Fig.   2f ). This site contains two conserved juxtaposed TpitRE palindromic sequences 23 and exhibits the chromatin signature (H3K4me1, H3K27ac and FAIREseq peak) of active enhancer sequences. When directly tested in a luciferase reporter assay, this sequence behaved as a bona fide Tpit-responsive enhancer ( Fig. 2g ). Altogether, these results identify Creb3l2 as a major Tpit target gene.
Translation and secretory capacity
In order to evaluate in vivo the putative roles of Creb3l2 and XBP1, we performed loss-and gain-of function (LOF, GOF) experiments. Because Creb3l2 or XBP1 germline inactivation lead to perinatal or embryonic lethality 24, 25 , we used a pituitary POMC cell specific dominantnegative (DN) approach. Replacement of the basic region of bZIP proteins by an acidic (A) sequence (AZIP) was shown to be a very efficient and specific way to inactivate endogenous bZIP factors 26 (Fig. 3a ). We generated ACreb3l2 and AXBP1 constructs and validated their efficiency and specificity using a 3xCreb3l2-RE-luc reporter in both activated and basal conditions ( Fig. 3b and Supplementary Fig. S2a, b ). To inhibit Creb3l2 or XBP1 in pituitary POMC cells, we expressed ACreb3l2 or AXBP1 in transgenic mice using the POMC promoter, previously shown to be specific and penetrant in melanotrope cells 15 . For each transgene, we selected two stable mouse lines with an AZIP versus endogenous bZIP mRNA ratios >5, ensuring strong inhibition of the endogenous TF ( Fig. 3b and Supplementary Fig. S2c, d ). Both transgenic lines behaved similarly and results are shown for one line. Total RNA content of transgenic ILs was reduced with synergistic effects in double ACreb3l2/AXBP1 transgenic mice ( Fig. 3c ). Also, ACreb3l2 and AXBP1 increased IL nuclear density, reflecting a reduction in melanotrope cell size ( Fig. 3d, e ).
To complement these in vivo LOF models, we assessed the consequences of Creb3l2 or/and XBP1 overexpression (GOF) on size and secretory capacity of POMC cells by generating stable populations of AtT-20 cells that overexpress active forms of Creb3l2 (cleaved Creb3l2) and/or XBP1 (spliced XBP1). Expression of Creb3l2, XBP1 or both led to a similar increase of AtT-20 cell size and granularity ( Fig. 3f , g). In contrast, Creb3l2, but not XBP1, overexpression resulted in higher RNA contents, and this effect is even greater in Creb3l2+XBP1 overexpressing cells ( Fig. 3h ). Hence, Creb3l2 and XBP1 are controlling overlapping (cell size and organelles) and unique (RNA content) aspects of secretory capacity.
As the Tpit-dependent transcriptome (Fig. 2b , c) identified translation and ER biogenesis, we assessed these functions in the in vivo LOF and AtT-20 GOF models. Strikingly, Creb3l2, but not XBP1, inhibition led to a specific reduction of translation rate ( Fig. 3I ), as assessed by the puromycin incorporation assay 27 . This effect fully mimics the loss of Tpit. In contrast, ER content is dependent on XBP1, but not Creb3l2 (Fig. 3j ), and XBP1 inhibition also mimics the Tpit KO phenotype. Altogether, these results show that Creb3l2 and XBP1 have different activities, namely regulation of translation and ER biogenesis, respectively. Consistent with the role of Creb3l2 in translation, Creb3l2, but not XBP1 overexpressing cells have higher total protein content ( Fig. 3k ). An even greater increase was observed in Creb3l2+XBP1 overexpressing cells.
We also assessed the impact of Creb3l2 and XBP1 on the regulated secretory pathway 28 by measuring ACTH release in response to corticotropin-releasing hormone (CRH). Both, Creb3l2 and XBP1 overexpression improved CRH response, with a synergistic effect in Creb3l2+XBP1 cells ( Fig. 3l ). Collectively, these results suggest that Creb3l2 and XBP1 are jointly regulating the development of secretory function.
The Akt/ mTOR pathway regulates translation in response to growth factors; in order to assess whether this pathway is involved in the action of Creb3l2, we measured by Western blot the levels of phospho-mTOR and mTOR. These are largely unaltered by Tpit KO, the ACreb or AXBP1 transgenes ( Supplementary Fig. S2e ) suggesting that Creb3l2 may act downstream of this pathway.
Creb3l2 targets the promoters of translation genes
In order to define the mechanism by which Creb3l2 may enhance translation capacity and to document XBP1 action on the physiological UPR pathway, we performed ChIPseq for both factors in AtT-20 cells. We observed 6484 Creb3l2 recruitment peaks, while XBP1 ChIPseq produced fewer peaks (258) similar to observations made in other cells 29, 30 . Contrary to many TFs such as Tpit that are mostly recruited at enhancers, 41% of Creb3l2 and XBP1 peaks are found at promoters ( Supplementary Fig. S3a -c). While XBP1 targets genes involved in ER biogenesis ( Supplementary Fig. S3d ) in agreement with previous reports 29 GO analysis of genes associated with Creb3l2 peaks confirmed enrichment of categories related to translation, protein transport, and RNA processing ( Fig. 4e ), while XBP1-associated genes correspond to ER stress/UPR ( Supplementary Fig. S3d ). These associations mostly occur at promoters/proximal regions of target genes ( Fig. 4e and Supplementary Fig. S3d , bottom panels). Collectively, these data show targeting of two subsets of genes involved in secretory function, namely genes involved in translation and protein transport (controlled by Creb3l2) and ER biogenesis (controlled by XBP1).
Analysis of the ChIPseq data for de novo motifs revealed conserved sequence motifs for Creb3l2 and XBP1 ( Supplementary Fig. S4a, b ) that are consistent with prior work 22, 23, 29, 31 .
Creb3l2 and XBP1 peaks were associated with bZIP motifs containing the core ACGT sequence. A reporter containing three copies of the Creb3l2-RE upstream of a minimal promoter as well as a natural promoter (Ssr3) and enhancer (Kcnma1) were activated dosedependently by both Creb3l2 and XBP1 ( Fig. 4f and Supplementary S4c, d). Thus, Creb3l2
and/or XBP1 directly activate genes involved in translation and secretory system development.
In order to better assess the extent of Creb3l2 targeting of genes involved in translation, we computed the number of genes encoding translation initiation (eIF), elongation (eEF) and termination (eTF) factors as well as ribosomal protein coding genes and those for aminoacyl tRNA synthethases that are directly targeted by Creb3l2 binding (within 100 bp of their TSS) based on the ChIPseq data. This showed direct targeting of 70-80 % of these genes depending of the sub-categories ( Fig. 4g , Supplementary Table S2 ). Collectively, these data indicate that Creb3l2 is acting very broadly on a large number of translation regulatory and effector genes in order to enhance translation capacity. This situates the Creb3l2 cellautonomous action downstream of the signaling pathways that are usually implicated in translational control, such as the Akt/mTOR pathway.
Creb3l2, a translation scaling factor
To evaluate to which extent gene expression changes dependent on Creb3l2 or/and XBP1 resemble gene expression changes caused by Tpit inactivation, we performed RNAseq on our LOF and GOF models and analyzed the results by unsupervised clustering analysis. Four gene clusters (A-D) were identified and analyzed by Gene Ontology (GO) (Fig. 5a ). Two clusters appeared to be particularly interesting: clusters A and C. Cluster A is enriched in genes controlling protein transport and translation that tend to be downregulated in Tpit KO tissues. The same tendency is observed for these genes in ACreb3l2 and AXBP1 transgenic mice, and even more in combined ACreb3l2/AXBP1 mice. Cluster A includes about 50% of the genes in each translation sub-category ( Fig. 4g ). Hence, combined downregulation of Creb3l2 and XBP1 phenocopies the effect of Tpit deficiency on translation and secretory pathway genes.
Cluster C represents a group of genes synergistically downregulated in Creb3l2+XBP1 cells and it is enriched in genes controlling hexose metabolism. Their analysis suggested a shift from glycolysis to oxidative phosphorylation utilization of glucose and in agreement with this, mRNA levels of lactate dehydrogenase (Ldha) and pyruvate dehydrogenase kinase (Pdk1) are decreased in Creb3l2+XBP1 cells ( Fig. 5b) . Accordingly, the latter cells exhibit decreased lactate production and glucose utilization ( Fig. 5c ). We directly assessed cell respiration and found increased ATP turnover only in Creb3l2+XBP1 cells ( Fig. 5c ). Since AtT-20 cells are tumor-derived, they are likely to exhibit a Warburg shift towards glycolytic glucose utilization compared to normal pituitary cells. The Creb3l2-dependent reverse shift towards the more energy efficient mitochondrial oxidative phosphorylation pathway is consistent with the high energy requirements for translation and the development of a high capacity secretory system.
In order to assess conservation of Creb3l2 and UPR regulators in an evolutionary distant but related system, we queried their status in the Xenopus IL where melanotrope cell size and αMSH secretion increase when frogs adapt to a dark background environment 17, 32 . We found that IL RNA content ( Fig. 5d ) and expression levels of UPR pathway regulators, including
Creb3l2, are increased in dark-adapted frogs (Fig. 5e ). Thus, the physiological UPR pathway appears an evolutionary conserved mechanism to match secretory capacity with translational burden.
To our knowledge, Creb3l2 is the first TF shown to directly target and regulate the translation transcriptome. Creb3l2 is expressed in many secretory tissues ( Supplementary Fig. S1f) including in pancreatic islets. While pituitary POMC cell maturation is regulated by Tpit, pancreatic β cell maturation is dependent on the TF Pdx1. Interestingly, Pdx1 binding is observed at the Creb3l2 promoter in islet cells ( Supplementary Fig. S4e ) suggesting a maturation mechanism that may resemble that of POMC cells. To assess Creb3l2 activity in β cells, we stably overexpressed Creb3l2 in insulin-secreting INS-1 cells and found an increase of INS-1 cell size, granularity and a 36% increase of translational rate ( Fig. 5f-h) .
Thus, Creb3l2 appears to be a general regulator of translation capacity.
Discussion
The present work identified a master TF for control of translation capacity, Creb3l2. Genomewide approaches demonstrated that Creb3l2 is directly targeting and stimulating transcription of hundreds of genes involved in different steps of translational control, namely 55 translation factors, 105 ribosomal proteins and 30 aminoacyl tRNA synthetases genes. Genetic manipulations (LOF, GOF) of the Creb3l2 gene in mice and two different secretory cell types led to significant changes of translation rates (25-36%). Overexpression of Creb3l2 was sufficient to increase overall cellular protein content by ≈25%. Scaling factors were proposed to be factors that adjust expression of genes controlling basic cell functions to specific cellular needs 33 . Creb3l2 is thus a scaling factor for translation.
It is noteworthy that total RNA content is increased following Creb3l2 action. Although we could not find evidence of direct Creb3l2 binding to rRNA genes, its broad action on expression of ribosomal proteins is likely sufficient to increase rRNA transcription and hence, have a significant effect on total RNA content. It was indeed shown that depletion of ribosomal proteins RPS19, RPS6 or RPL11 is sufficient to decrease rRNA transcription 34 .
The present work suggests a general paradigm that involves three TFs for maturation of secretory cells into hormone-producing factories (Fig. 6) . A tissue-specific terminal differentiation factor (Tpit in pituitary POMC cells, Pdx1 in pancreatic islet cells) that upregulates two bZIP TFs, Creb3l2 for scaling up translation capacity and XBP1 to increase secretory organellogenesis without triggering the stress response. These physiological regulators of secretory capacity could be useful to increase yields of therapeutic proteins such as cytokines and monoclonal antibodies that are produced by expression in mammalian cells.
The involvement of the UPR regulator XBP1 in this regulatory network clearly fits within the context of the so-called "physiological"UPR" system rather than within the cytoprotective homeostatic response to protein stress. The "physiological UPR" was described in professional secretory cells, such as B lymphocytes, digestive enzyme-secreting zymogenic cells, salivary glands, exocrine pancreas or pancreatic beta cells 1, [35] [36] [37] . This proactive UPR engagement is preparing mature secretory cells to massive protein synthesis and secretion, rather than being a response to high secretory load. The existence of two types of UPR (i.e. stress related and physiological) raises the question of how context-dependent UPR specificity is achieved. The stress-related UPR involves three sub-pathways characterized by different ER transmembrane sensor proteins, IRE1, PERK and ATF6. A clearly undesirable aspect of UPR in highly secreting cells is the PERK branch that leads to global translational repression by phosphorylation and inhibition of eIF2α 38 . Interestingly, PERK expression is barely affected by loss of Tpit but expression of Gadd34/Myd116, a phosphatase reversing eIF2α phosphorylation is positively regulated by Tpit. In fact, Tpit action not only seems to exclude PERK, but also prepare POMC cells to neutralize PERK activation. Also, genes related with ER associated protein degradation (ERAD genes) are mostly unaffected in Tpit-/-pituitaries.
Another undesirable UPR effect in physiological conditions is the apoptotic response that follows prolonged ER stress (reviewed in 39 ). In Tpit-/-IL, the expression of CHOP/Ddit3, a major mediator of ER stress-induced apoptosis is not affected. During ER stress, apoptosis can be delayed through expression of inhibitors of apoptosis (IAPs) proteins [40] [41] [42] . Expression of two IAPs (Naip5 and Naip6) is strongly dependent on Tpit and Tpit binding is observed at these genes (not shown). Thus, Tpit protects POMC cells from apoptotic signals. Collectively, these results suggest that Tpit sets up an efficient secretory system by activating "useful" (XBP1, Creb3l2) but not detrimental (PERK, CHOP/Ddit3) UPR regulators and stimulating inhibitors of deleterious UPR effects (the eIF2α phosphatase Gadd34/Myd116 and inhibitors of apoptosis Naip5 and Naip6).
Importantly, in addition to XBP1 stimulation of ER biogenesis, XBP1 has a synergistic effect on protein synthesis in combination with Creb3l2, increasing the overall cellular protein content by ≈50% with resulting enhancement of regulated secretion. Translation is the most energy consuming (about 70%) cellular process 43 and uncontrolled protein synthesis leads to apoptosis 44 ; in the latter work on translational activation through the PERK pathway mediated by ATF4 and CHOP 44 , it is noteworthy that the group of stimulated translation control genes included primarily tRNA aminoacylation in contrast to the broad set identified in the present work. Remarkably, the combined Creb3l2 plus XBP1 expression in the tumor-derived AtT-20 cells led to a shift of energy metabolism from glycolysis to oxidative phosphorylation, resulting in more efficient ATP production and providing for support of heavy protein synthesis.
In summary, the present work identified Creb3l2 as a scaling factor for translation and showed that its joint action with XBP1 dramatically increases protein synthesis and secretory capacity.
The targets of Creb3l2 and XBP1 action are revealing of their purpose. By targeting genes that are downstream within the Creb3l2 regulatory network (Fig. 6 ), this TF sets the cellautonomous "rheostat" for translation capacity, in this instance setting high level capacity. And the joint action of XBP1 on the physiological UPR pathway matches this with increased secretory capacity. This reset of protein secretion capacity is separate from, and therefore compatible with, upstream signaling pathways regulating translation such as the Akt/mTOR pathway.
Methods

Animals and genotyping
The generation and genotyping of Tpit KO (BALB/c) and POMC-EGFP transgenic (C57BL/6) mice was described elsewhere 15, 20 . Pomc-KO (C57BL/6) mice 45 intron and polyadenylation sequences were microinjected and founder lines were derived as previously described 15 .
Histology and electron microscopy
Processing of PFA-fixed, paraffin-embedded pituitaries and immunohistofluorescence were done as described 46 . For electron microscopy, adult (4-6 month-old) mice were first perfused with PBS without potassium (10 ml/mice at 2 ml/min), then with 2.5% glutaraldehyde (20 ml/mice at 2 ml/min). Pituitaries were then dissected and post-fixed in 2.5% glutaraldehyde for 2h at +4°C. EM was performed as previously described 47 Translation rate. Translation monitoring was done using the principles of surface sensing of translation (SUnSET) 27 adapted for in vivo studies 48 . Briefly, adult (3-6 months) mice were intraperitoneally injected with 100 µl of 7 mg/ml puromycin dihydrochloride (Gibco A1113803) solution (0.04 µmol/kg). 30 min after injection ILs were extracted, and melanotrope cells prepared as described 49 Metabolic studies in different AtT-20 cell populations (respiration, lactate and glucose levels)
were performed as described 51 .
Transient transfections. αT3 (Fig. 2g ), GH3 ( Fig. 4f and Suppl. Fig. S4c,d ) or INS-1 (Fig. 3b and Suppl. Fig. S2a,b ) cells were plated in 12-well plates (3x10 5 cells/well) the day preceding transfection and transfected with 1.4 µg of DNA, containing 100 ng of luciferase reporter construct with different amounts of expression vectors completed with empty expression vector (JA1394) using Lipofectamine reagent (Invitrogen, Carlsbad, CA).
DNA Vectors
Supplementary Table S3 lists reagents used to construct all expression vectors, including relevant PCR primers and used restriction sites. 
Chromatin Immunoprecipitationsequencing (ChIPseq)
ChIP experiments were performed in AtT-20 cells as previously described 54 H3K27ac ChIPseq is described 55 and available on GEO as GSE 87185. 56 or AmiGO1
Bioinformatics processing and analysis of genomic data
(http://amigo1.geneontology.org/cgi-bin/amigo/term_enrichment) 57, 58 . P-values on DAVID ( Fig. 2b) correspond to EASE Score, a modified (more conservative) Fisher Exact P-value, while P-values on AmiGO (Fig. 4e) were calculated with GO::TermFinder using the hypergeometric distribution. The heat map of transcriptomic microarray data was visualized using the TreeView Java application 59 .
ChIPseq peak finding and sequence analysis were described previously 22 . For de novo motif analysis, 120 bp of sequences surrounding the peaks were extracted from the University of California at Santa Cruz Web site 60 and processed using HOMER 61 66 ). After normalization, we applied K-means for clustering using Euclidean distance similarity metrics. We determined that 4 clusters is the most segregating setting for our dataset. The gene lists extracted from those 4 clusters were uploaded into the DAVID website 56 to search for enriched biological processes. 
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